UTMD
Utah Medical Products Inc
NASDAQ: UTMD · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$65.42
+0.60% today
Updated 2026-04-30
Market cap
$207.06M
P/E ratio
19.24
P/S ratio
5.52x
EPS (TTM)
$3.38
Dividend yield
1.85%
52W range
$51 – $72
Volume
0.0M
Utah Medical Products Inc (UTMD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$65.42
12-Month target
$63.76
2030 Target
—
Intrinsic (DCF)
$51.90
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 19.24x (capped 25x) · Margin: 28.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.